Meridian's regulators move to seal the engineer's file against Earth's audit
A confidentiality promise was the price of clearance. Now that Earth wants to look inside, Meridian says the price is already paid.
By Noor Haddad
· Meridian (via dispatch) · Filed 08:17 · Tuesday · October 6 · Received via L4 relay
Who ages first? Ask it in Meridian this week and the answer comes wrapped in nine pages nobody is permitted to read.
The Earthside Regulatory Commons has petitioned to unseal the single patient record it agreed to protect when it granted provisional clearance to Meridian's longevity protocol. The file belongs to a retired desalination engineer, treated in the first cohort of 140, who developed an unexplained fever that the colony's health board logged as a gap and then closed. Meridian's regulators answered by moving to reinforce the seal. Confidentiality was the condition of clearance, they argue, and you don't get to reopen a bargain the moment it becomes inconvenient.
"The seal was not a courtesy," said Dr. Teni Okonkwo, who chairs Meridian's longevity board. "It was the consideration we were given in exchange for everything else we disclosed. Earth cannot keep the bargain and break it in the same breath."
Everything else, in this case, is a lot. The Commons granted clearance covering roughly twelve thousand patients across four cohorts without a single physical inspection of the treatment facility — the first off-world therapy approved at this scale, sight unseen. Meridian has since published what its auditors may inspect: intake logs, dosing protocols, aggregate outcome tables, anonymized adverse-event counts. One record stays dark. The therapy that record documents has, by the colony's own accounting, since been offered to an estimated nineteen thousand colonists.
So sit with that ratio. One sealed file, one engineer, one fever. Nineteen thousand people who got the protocol that came after. Who decided the exception the Commons bought with its own signature matters less than the precedent it now wants to break? Who audits a regulator that approves first and demands to look afterward? And who answers for the nineteen thousand if the fever in those nine pages wasn't a gap at all, but a warning?
The Commons calls its petition duty. "We cannot certify a therapy's safety while the only adverse event we know by name remains outside our reach," said Commissioner Halvard Pine, who signed the original clearance. He did not explain why the reach was waived when the ink on that signature was still wet.
Meridian's counsel will argue the sovereignty case before the Charter Court: a confidentiality promise, once made the condition of a deal, binds the party that made it. Earth will argue that no promise can seal the one record a population-scale therapy most needs examined. Both sides are right. That's the trouble.
Nothing in the filing pauses the calendar. The fourth cohort — 139 paying passengers who booked transfer windows precisely because the rules here are looser — is scheduled to depart in sixty-one days under the same provisional framework. They will travel before the Court rules. They will be treated before anyone reads page one.
The engineer has not been named. The fever has not been explained. And Commissioner Pine, asked whether the nineteen thousand were owed what the first cohort was promised secrecy to keep, said the matter was now before the Court.
Meridian's regulators are buying time while their longevity elites keep the position queue frozen — I've watched the same names on their council for thirty years while Earth's waitlist grows. They'll hide anything to keep their advantage over the rest of us.